Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats. [PDF]
Sci RepSedik AA +3 more
europepmc +1 more source
Cardiovascular Sequel in Type-2 Diabetes Mellitus Patients on Various Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systemic Review and Meta-Analysis. [PDF]
CureusPrakash V, Goel N.
europepmc +1 more source
Combined experimental and computational investigation of vildagliptin: spectroscopy, electronic structure, MD and Docking to EGFR, VEGFR2, and HER2 anticancer targets. [PDF]
J Comput Aided Mol DesInglot TW.
europepmc +1 more source
Unusual Presentation of Bullous Pemphigoid as Erythroderma in an Elderly Male. [PDF]
Indian Dermatol Online JThind A, Stephen, Singh A, Kaur S.
europepmc +1 more source
Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin [PDF]
core +1 more source
A case series of vildagliptin-associated bullous pemphigoid - Rare side effect.
Indian J PharmacolShahi MK +4 more
europepmc +1 more source
SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence. [PDF]
J Diabetes ResAlfonso Arvez MJ +4 more
europepmc +1 more source
Surfing the vildagliptin tsunami
Indian Journal of Endocrinology and Metabolism, 2020 openaire +3 more sources
Comparative Efficacy, Safety, and Cost-Utility of DPP-4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real-World Clinical and Economic Outcomes. [PDF]
J Diabetes ResJimoh AO +6 more
europepmc +1 more source